Sanofi Prices €2.3 Billion in Bond Offering

On April 24, 2026, Sanofi announced the successful pricing of its €2.3 billion bond issue, structured in three tranches. The offering includes €1,000 million with a fixed rate maturing in 2029 at 3.000% interest, €650 million maturing in 2033 at 3.375%, and €650 million due 2037 at 3.750%.

The notes fall under Sanofi's Euro Medium Term Note program. Proceeds will support Sanofi's general corporate initiatives. Citigroup, HSBC, and J.P. Morgan led the transaction, with Credit Agricole CIB, Deutsche Bank, RBC Capital Markets, and Unicredit as joint lead managers.

Sanofi emphasized compliance with regulations regarding offer and sale, particularly within the EEA and UK. The notes target qualified investors, excluding retail investors in the European Economic Area and the UK.